Innovative Medicines Initiative (IMI) Calls 11 and 12 Open

IMI2 – Call 11 is a single-stage call for proposals and includes one topic on the exploitation of IMI project results. It focuses in particular on the following IMI projects: EMTRAIN and PharmaTrain (both education and training), EUPATI (patient education), Open PHACTS (data management), RAPP-ID (infectious disease diagnostics), WEB-RADR (reporting of medicines side effects), and GetReal (incorporation of real world data into drug development).

IMI2 – Call 12 is a standard, two-stage call for proposals and includes the following topics:

Development and validation of technology enabled, quantitative and sensitive measures of functional decline in people with early stage Alzheimer’s disease (RADAR-AD)

• FAIRification of IMI and EFPIA data
• Development of sensitive and validated clinical endpoints in primary Sjögren’s Syndrome (pSS)
• European health data network (EHDN)
• Analysing the infectious disease burden and the use of vaccines to improve healthy years in aging populations
• Discovery and characterisation of blood-brain barrier targets and transport mechanisms for brain delivery of therapeutics to treat neurodegenerative & metabolic diseases
• European Screening Centre: unique library for attractive biology (ESCulab)

Deadline for submitting proposals (both Calls): 24 October 2017.

Find out more

All topic texts, call documentation and details of how to apply can be found on the IMI website.

Webinars

Webinars on all IMI2 – Call 12 topics, as well as IMI’s rules and procedures, have taken place and the presentations and recordings are available online.

A webinar on IMI2 – Call 11 will be held on Wednesday 26 July 2017 at 14.30. Registration is free but obligatory.

Tips on finding partners and preparing your proposal

The IMI website includes pages with tips for applicants and guidance on how to find project partners.